{"id":235379,"date":"2023-08-01T06:35:38","date_gmt":"2023-08-01T06:35:38","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=235379"},"modified":"2023-08-01T06:35:38","modified_gmt":"2023-08-01T06:35:38","slug":"groenouws-corneal-dystrophy","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/groenouws-corneal-dystrophy\/","title":{"rendered":"Groenouw&#8217;s corneal dystrophy"},"content":{"rendered":"<p>This is an inherited eye disorder that exists in two forms: type I (granular) and type II (macular).<\/p>\n<hr \/>\n<p>Granular corneal dystrophy is an autosomal dominant disorder\u00a0characterized by small granular opacities in the top layers of the cornea. It develops in the first ten years of life. Macular corneal dystrophy is an autosomal recessive disorder typified by a diffuse haze with areas of dense corneal opacity. It develops in young people up to the age of 20.<\/p>\n<hr \/>\n<div class=\"group w-full text-gray-800 dark:text-gray-100 border-b border-black\/10 dark:border-gray-900\/50 bg-gray-50 dark:bg-[#444654] sm:AIPRM__conversation__response\">\n<div class=\"flex p-4 gap-4 text-base md:gap-6 md:max-w-2xl lg:max-w-[38rem] xl:max-w-3xl md:py-6 lg:px-0 m-auto\">\n<div class=\"relative flex w-[calc(100%-50px)] flex-col gap-1 md:gap-3 lg:w-[calc(100%-115px)]\">\n<div class=\"flex flex-grow flex-col gap-3\">\n<div class=\"min-h-[20px] flex items-start overflow-x-auto whitespace-pre-wrap break-words\">\n<div class=\"markdown prose w-full break-words dark:prose-invert light AIPRM__conversation__response\">\n<p>The management of discomfort related to this disorder may involve the use of antibiotic eye-drops. In more severe instances, laser surgery or a corneal transplant might be necessary.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>This is an inherited eye disorder that exists in two forms: type I (granular) and type II (macular). Granular corneal dystrophy is an autosomal dominant disorder\u00a0characterized by small granular opacities in the top layers of the cornea. It develops in the first ten years of life. Macular corneal dystrophy is an autosomal recessive disorder typified [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-235379","post","type-post","status-publish","format-standard","hentry","category-g"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Groenouw&#039;s corneal dystrophy - Definition of Groenouw&#039;s corneal dystrophy<\/title>\n<meta name=\"description\" content=\"This is an inherited eye disorder that exists in two forms: type I (granular) and type II (macular).Granular corneal dystrophy is an autosomal dominant disorder\u00a0characterized by small granular opacities in the top layers of the cornea. It develops in the first ten years of life. Macular corneal dystrophy is an autosomal recessive disorder typified by a diffuse haze with areas of dense corneal opacity. It develops in young people up to the age of 20.The management of discomfort related to this disorder may involve the use of antibiotic eye-drops. In more severe instances, laser surgery or a corneal transplant might be necessary.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/groenouws-corneal-dystrophy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Groenouw&#039;s corneal dystrophy - Definition of Groenouw&#039;s corneal dystrophy\" \/>\n<meta property=\"og:description\" content=\"This is an inherited eye disorder that exists in two forms: type I (granular) and type II (macular).Granular corneal dystrophy is an autosomal dominant disorder\u00a0characterized by small granular opacities in the top layers of the cornea. It develops in the first ten years of life. Macular corneal dystrophy is an autosomal recessive disorder typified by a diffuse haze with areas of dense corneal opacity. It develops in young people up to the age of 20.The management of discomfort related to this disorder may involve the use of antibiotic eye-drops. In more severe instances, laser surgery or a corneal transplant might be necessary.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/groenouws-corneal-dystrophy\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-01T06:35:38+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/groenouws-corneal-dystrophy\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/groenouws-corneal-dystrophy\/\",\"name\":\"Groenouw's corneal dystrophy - Definition of Groenouw's corneal dystrophy\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2023-08-01T06:35:38+00:00\",\"dateModified\":\"2023-08-01T06:35:38+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"This is an inherited eye disorder that exists in two forms: type I (granular) and type II (macular).Granular corneal dystrophy is an autosomal dominant disorder\u00a0characterized by small granular opacities in the top layers of the cornea. It develops in the first ten years of life. Macular corneal dystrophy is an autosomal recessive disorder typified by a diffuse haze with areas of dense corneal opacity. It develops in young people up to the age of 20.The management of discomfort related to this disorder may involve the use of antibiotic eye-drops. In more severe instances, laser surgery or a corneal transplant might be necessary.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/groenouws-corneal-dystrophy\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/groenouws-corneal-dystrophy\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/groenouws-corneal-dystrophy\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Groenouw&#8217;s corneal dystrophy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Groenouw's corneal dystrophy - Definition of Groenouw's corneal dystrophy","description":"This is an inherited eye disorder that exists in two forms: type I (granular) and type II (macular).Granular corneal dystrophy is an autosomal dominant disorder\u00a0characterized by small granular opacities in the top layers of the cornea. It develops in the first ten years of life. Macular corneal dystrophy is an autosomal recessive disorder typified by a diffuse haze with areas of dense corneal opacity. It develops in young people up to the age of 20.The management of discomfort related to this disorder may involve the use of antibiotic eye-drops. In more severe instances, laser surgery or a corneal transplant might be necessary.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/groenouws-corneal-dystrophy\/","og_locale":"en_US","og_type":"article","og_title":"Groenouw's corneal dystrophy - Definition of Groenouw's corneal dystrophy","og_description":"This is an inherited eye disorder that exists in two forms: type I (granular) and type II (macular).Granular corneal dystrophy is an autosomal dominant disorder\u00a0characterized by small granular opacities in the top layers of the cornea. It develops in the first ten years of life. Macular corneal dystrophy is an autosomal recessive disorder typified by a diffuse haze with areas of dense corneal opacity. It develops in young people up to the age of 20.The management of discomfort related to this disorder may involve the use of antibiotic eye-drops. In more severe instances, laser surgery or a corneal transplant might be necessary.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/groenouws-corneal-dystrophy\/","og_site_name":"Glossary","article_published_time":"2023-08-01T06:35:38+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/groenouws-corneal-dystrophy\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/groenouws-corneal-dystrophy\/","name":"Groenouw's corneal dystrophy - Definition of Groenouw's corneal dystrophy","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2023-08-01T06:35:38+00:00","dateModified":"2023-08-01T06:35:38+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"This is an inherited eye disorder that exists in two forms: type I (granular) and type II (macular).Granular corneal dystrophy is an autosomal dominant disorder\u00a0characterized by small granular opacities in the top layers of the cornea. It develops in the first ten years of life. Macular corneal dystrophy is an autosomal recessive disorder typified by a diffuse haze with areas of dense corneal opacity. It develops in young people up to the age of 20.The management of discomfort related to this disorder may involve the use of antibiotic eye-drops. In more severe instances, laser surgery or a corneal transplant might be necessary.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/groenouws-corneal-dystrophy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/groenouws-corneal-dystrophy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/groenouws-corneal-dystrophy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Groenouw&#8217;s corneal dystrophy"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/235379","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=235379"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/235379\/revisions"}],"predecessor-version":[{"id":235380,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/235379\/revisions\/235380"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=235379"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=235379"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=235379"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}